Radiation Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  
Selim Y. Firat, MD

Selim Y. Firat, MD
Assistant Professor of Radiation Oncology

Department of Radiation Oncology
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 805-4453

Curriculum Vitae

Patient Care Emphases

  • Pediatric Malignancies & Pediatric Radiation Oncology
  • Head and Neck Tumors
  • General Radiation Oncology

Clinical Practice Locations

Education

  • Doctor of Medicine,  Hacettepe University Faculty of Medicine, Ankara, Turkey (1996).

Training

  • Board Certification, Radiation Oncology, American Board of Radiology (2002).
  • Residency Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI (1997-2001).

 Additional Language Spoken

  • Turkish

Representative Publications (last 5 years)

  • Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson BA, Wang D, Schultz, CJ, Firat SY, Wilson JF.  Interfractional variations in patient setup and anatomic changes assessed by daily computed tomography.  Int J Radiat Oncol Biol Phys, 68(2):581-91, 2007.
  • Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H.  Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent source brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. 
  • Lee WR, Bae K, Lawton CA, Gillin MT, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H. A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology  Group P0019.  Brachytherapy, 5(4):239-43, 2006. 
  • Firat S, Pleister A, Byhardt RW, Gore E.  Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). American Journal of Clinical Oncology, 29(3):252-7, 2006. 
  • Lee WR, Desilvio M, Lawton C, Gillin M, Morton G. Firat S, Baikadi M, Kuettel M, Greven K, Sandler H.  A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG 0019.  Int J Radiat Oncol Biol Phys,64(3):804-9, 2006.  
webmaster@mcw.edu
© 2009 Medical College of Wisconsin
Page Updated 11/17/2009